Skip to content

A Study Protocol for Developing a Prediction Model: Assisting in Predicting for Von Willebrand disease High-Risk Patients Often Overlooked in Daily Practice (VASC-HemO)

A Study Protocol for Developing a Prediction Model: Assisting in Predicting for Von Willebrand disease High-Risk Patients Often Overlooked in Daily Practice (VASC-HemO)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102986
Enrollment
Unknown
Registered
2025-05-22
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Von Willebrand Disease (VWD)

Interventions

Gold Standard:One of the following conditions is met:1. VWF level (VWF antigen or activity) <30%
2. The VWF level (VWF antigen or activity) is 30%~50%, and the patient shows bleeding symptoms
3. FVIII activity/VWF antigen level < 0.7 and abnormal FVIII:VWF binding.
Index test:The candidate predictive variables include age, gender, clinical manifestations, complete blood count (CBC), and coagulation panel. Based on these variables, various artificial intelligence

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) At least one bleeding manifestation: epistaxis, skin ecchymosis, small wound bleeding, oral bleeding, gastrointestinal bleeding, hematuria, bleeding after tooth extraction, postoperative bleeding, menorrhagia, postpartum hemorrhage, muscle hematoma, hemarthrosis or central nervous system hemorrhage; (2) Platelet count>=100×10^9/L; (3) Fibrinogen level>=1.5 g/L; (4) D-dimer level<=500 µg/L.

Exclusion criteria

Exclusion criteria: (1) Presence of clinically confirmed severe underlying diseases, including: chronic kidney disease stage 4-5 (eGFR 80 years old.

Design outcomes

Primary

MeasureTime frame
Coagulation factors;Complete blood count;Coagulation panel;

Countries

China

Contacts

Public ContactJing Dai

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

dj40572@rjh.com.cn+86 18917762831

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026